You are here

Merck KGaA

Merck KGaA's phase 3 rare tumor trial hits goal, teeing up rivalry with Daiichi and Ono

Fierce Biotech

Tue, 11/12/24 - 09:47 am

tenosynovial giant cell tumors

clinical trials

Pharma’s ‘it’ therapy — a new drug class gaining steam

Pharma Voice

Wed, 09/4/24 - 11:30 am

protein degradation

After sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound

Fierce Pharma

Wed, 08/7/24 - 11:00 pm

Takeda to cut another 220 jobs in Massachusetts, while Merck KGaA plots its own layoffs

Fierce Pharma

Tue, 07/2/24 - 11:12 am

Merck KGaA cans head and neck cancer drug once hailed as big hope

Pharmaphorum

Tue, 06/25/24 - 11:49 am

head and neck cancer

clinical trials

Merck KGaA's MilliporeSigma devotes €62M to new quality control building in Germany

Fierce Pharma

Fri, 06/14/24 - 11:22 am

quality control

drug manufacturing

Top ten biopharma R&D deals of 2024

Nature

Wed, 06/5/24 - 11:24 am

Argo Biopharmaceutical

MOMA Therapeutics

Boehringer Ingelheim

Suzhou Ribo Life Science

Isomorphic Labs

Gilead Sciences

Umoja Biopharma

Caris Life Sciences

Voyager Therapeutics

Merck KGaA taps AI-focused biotech for new ADC pact worth $376M

Fierce Biotech

Tue, 06/4/24 - 11:33 am

Biolojic Design

antibody-drug conjugates

ASCO: Merck KGaA, Pfizer's Bavencio combo misses survival mark in crowded kidney cancer space

Fierce Pharma

Thu, 05/23/24 - 09:52 pm

clinical tirals

Merck KGaA to buy gene therapy tools maker for $600M

BioPharma Dive

Thu, 05/23/24 - 09:37 pm

Gamma Biosciences

Merck KGaA unit avoids DOJ prosecution after exposing scheme to divert drugs to China

Fierce Pharma

Wed, 05/22/24 - 10:22 pm

Merck KGaA's CDMO unit continues to slide but company sees an uptick coming

Fierce Pharma

Wed, 05/15/24 - 10:50 pm

Germany's Merck breaks ground on $321m biomanufacturing center

BioProcess International

Thu, 04/25/24 - 05:57 pm

drug manufacturing

Merck KGaA signs $1.4B biobuck deal with Caris to expand ADC pipeline

Fierce Biotech

Thu, 04/4/24 - 11:17 am

antibody-drug conjugates

Caris Life Sciences

Merck KGaA's MilliporeSigma drops €300M on Korean biologics plant with plans to create 300 new jobs

Fierce Pharma

Thu, 03/21/24 - 06:39 pm

drug manufacturing

Despite pharma growth, Merck KGaA's CDMO slowdown plays into company's overall sales decline

Fierce Pharma

Sun, 03/10/24 - 08:40 pm

Merck KGaA bets on Inspirna’s colorectal cancer drug ompenaclid

Pharmaphorum

Thu, 01/4/24 - 10:09 am

colorectal cancer

Merck KGaA’s BTK Inhibitor Fails Phase III Multiple Sclerosis Studies

BioSpace

Wed, 12/6/23 - 10:44 am

clinical trials

relapsing multiple sclerosis

Merck KGaA buys into Abbisko’s late-stage joint tumor med for $70M upfront

Fierce Biotech

Tue, 12/5/23 - 11:07 am

Abbisko Therapeutics

Merck KGaA's pharma unit joins the healthcare migration to Boston's Seaport innovation hub

Fierce Pharma

Tue, 11/14/23 - 09:59 pm

Pages